Gul Majid Khan Selected Research

di-n-butyltin (dibutyltin)

1/2022

Dibutylstannanediyl (2Z,2'Z)-bis(4-(benzylamino)-4-oxobut-2-enoate inhibits prostate cancer progression by activating p38 MAPK/PPARα/SMAD4 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gul Majid Khan Research Topics

Disease

12	Cutaneous Leishmaniasis 01/2022 - 11/2018
4	Neoplasms (Cancer) 01/2022 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
2	Candidiasis (Moniliasis) 10/2020 - 07/2020
2	Wounds and Injuries (Trauma) 02/2020 - 03/2019
1	Mycoses (Diseases, Fungus) 07/2021
1	ST Elevation Myocardial Infarction 01/2021
1	Vulvovaginal Candidiasis 07/2020
1	Infections 02/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Hepatitis C 01/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Leishmaniasis 11/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2017
1	Leukemia 03/2017
1	Hypoglycemia (Reactive Hypoglycemia) 05/2016
1	Diabetes Mellitus 05/2016
1	Infertility (Sterility) 10/2008
1	Male Infertility (Male Sterility) 10/2008

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2022 - 08/2017
5	miltefosine (Impavido)IBA 01/2022 - 01/2020
4	Liposomes (Liposome)IBA 04/2021 - 11/2018
3	LipidsIBA 01/2021 - 07/2020
2	Amphotericin B (Amphotericin)FDA LinkGeneric 07/2020 - 01/2020
2	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 03/2020 - 11/2018
2	PolyphenolsIBA 01/2020 - 01/2019
1	Meglumine AntimoniateIBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	TinIBA 01/2022
1	Surface-Active Agents (Surfactants)IBA 01/2022
1	TrifluralinIBA 01/2022
1	di-n-butyltin (dibutyltin)IBA 01/2022
1	Biopolymers (Biopolymer)IBA 07/2021
1	carboxypolymethyleneIBA 03/2021
1	Ketoconazole (Nizoral)FDA LinkGeneric 03/2020
1	polycaprolactoneIBA 02/2020
1	carvacrolIBA 02/2020
1	triphenyltin (triphenyltin hydride)IBA 01/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Hepatitis C AntibodiesIBA 01/2020
1	HydrogelsIBA 03/2019
1	Cefazolin (Ancef)FDA LinkGeneric 03/2019
1	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 03/2019
1	AlginatesIBA 03/2019
1	PectinsIBA 03/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	AntibodiesIBA 01/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019
1	ResveratrolIBA 01/2019
1	AntioxidantsIBA 01/2019
1	PolymersIBA 08/2017
1	Chloroform (Trichloromethane)IBA 03/2017
1	Glipizide (Glucotrol)FDA LinkGeneric 05/2016
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 10/2008
1	Testosterone (Sustanon)FDA Link 10/2008
1	Hormones (Hormone)IBA 10/2008
1	Follicle Stimulating Hormone (Follitropin)FDA Link 10/2008

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2022
1	Percutaneous Coronary Intervention 01/2021
1	Medication Errors (Medication Error) 01/2018